Eur Rev Med Pharmacol Sci 2020; 24 (12): 6478-6479
DOI: 10.26355/eurrev_202006_21626

How to restructure the management of Italian oncological patients during and after COVID-19 pandemic?

A. Fabi, G. Ferretti, F. Cognetti

Division of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy. alessandra.fabi@ifo.gov.it

Free PDF Download

To cite this article

A. Fabi, G. Ferretti, F. Cognetti
How to restructure the management of Italian oncological patients during and after COVID-19 pandemic?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 12
Pages: 6478-6479
DOI: 10.26355/eurrev_202006_21626

Publication History

Published online: 30 Jun 2020

Keywords Related articles:

  1. Will a tumor pandemic come after the COVID-19 pandemic? Head and Neck cancer perspective
  2. The impact of heroin illicit market in the framework of COVID 19 pandemic
  3. Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19
  4. An update on novel COVID-19 pandemic: a battle between humans and virus
  5. Impact of COVID-19 on otolaryngology in Italy: a commentary from the COVID-19 task force of the Young Otolaryngologists of the Italian Society of Otolaryngology